Literature DB >> 28757704

Retinopathy in hepatitis C.

Won Sriwijitalai1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Year:  2017        PMID: 28757704      PMCID: PMC5516460          DOI: 10.4103/ojo.OJO_210_2016

Source DB:  PubMed          Journal:  Oman J Ophthalmol        ISSN: 0974-620X


× No keyword cloud information.
Sir, The recent publication on retinopathy seen in a patient with hepatitis C receiving interferon is very interesting.[1] Mathur et al. noted that “presence of hard exudates at any stage of therapy of hepatitis C could be an indicator of the severity of retinopathy with possible indication for stopping the drug.”[1] However, it is still questionable whether the problem is due to interferon treatment. According to a recent report by Cuthbertson et al.,[2] it is concluded that “this study does not support routine screening for retinopathy in patients treated with pegylated interferon and ribavirin for hepatitis C.”[2] Furthermore, it is noted that the hepatitis C can induce retinopathy without administration of interferon.[3] Spontaneous hemorrhage and retinopathy can occur at any time in the course of illness.[3]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  3 in total

1.  Clinical characteristics of hepatitis C virus-associated retinopathy.

Authors:  T Abe; A Nakajima; N Satoh; T Koizumi; S Sakuragi; T Ono; M Komatsu; O Masamune
Journal:  Jpn J Ophthalmol       Date:  1995       Impact factor: 2.447

2.  Is screening for interferon retinopathy in hepatitis C justified?

Authors:  F M Cuthbertson; M Davies; M McKibbin
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

3.  Unusual course of interferon-related retinopathy in chronic hepatitis C.

Authors:  Gaurav Mathur; Deependra V Singh; Ayush Singal
Journal:  Oman J Ophthalmol       Date:  2016 Sep-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.